Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Apr;52(4):315–316. doi: 10.1136/ard.52.4.315-b

Folate supplementation and methotrexate.

S L Morgan, J E Baggott, W J Koopman, C L Krumdieck, G S Alarcón
PMCID: PMC1005636  PMID: 8484704

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alarcón G. S., Schrohenloher R. E., Bartolucci A. A., Ward J. R., Williams H. J., Koopman W. J. Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression. Arthritis Rheum. 1990 Aug;33(8):1156–1161. doi: 10.1002/art.1780330816. [DOI] [PubMed] [Google Scholar]
  2. Andersen P. A., West S. G., O'Dell J. R., Via C. S., Claypool R. G., Kotzin B. L. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med. 1985 Oct;103(4):489–496. doi: 10.7326/0003-4819-103-4-489. [DOI] [PubMed] [Google Scholar]
  3. Baggott J. E., Vaughn W. H., Hudson B. B. Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotide. Biochem J. 1986 May 15;236(1):193–200. doi: 10.1042/bj2360193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hanrahan P. S., Russell A. S. Concurrent use of folinic acid and methotrexate in rheumatoid arthritis. J Rheumatol. 1988 Jul;15(7):1078–1080. [PubMed] [Google Scholar]
  5. Hine R. J., Everson M. P., Hardin J. M., Morgan S. L., Alarcòn G. S., Baggott J. E., Koopman W. J., Krumdieck C. L. Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation. Rheumatol Int. 1990;10(4):165–169. doi: 10.1007/BF02274842. [DOI] [PubMed] [Google Scholar]
  6. Morgan S. L., Baggott J. E., Vaughn W. H., Young P. K., Austin J. V., Krumdieck C. L., Alarcón G. S. The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum. 1990 Jan;33(1):9–18. doi: 10.1002/art.1780330102. [DOI] [PubMed] [Google Scholar]
  7. Olsen N. J., Callahan L. F., Pincus T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1987 May;30(5):481–488. doi: 10.1002/art.1780300501. [DOI] [PubMed] [Google Scholar]
  8. Stenger A. A., Houtman P. M., Bruyn G. A. Does folate supplementation make sense in patients with rheumatoid arthritis treated with methotrexate? Ann Rheum Dis. 1992 Aug;51(8):1019–1020. doi: 10.1136/ard.51.8.1019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Stewart K. A., Mackenzie A. H., Clough J. D., Wilke W. S. Folate supplementation in methotrexate-treated rheumatoid arthritis patients. Semin Arthritis Rheum. 1991 Apr;20(5):332–338. doi: 10.1016/0049-0172(91)90033-v. [DOI] [PubMed] [Google Scholar]
  10. Tishler M., Caspi D., Fishel B., Yaron M. The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum. 1988 Jul;31(7):906–908. doi: 10.1002/art.1780310712. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES